From Zanius to ADMA: ADMA - a new "adipocytokine'' and its potential role in metabolic syndrome

被引：0
作者：
Kielstein, Jan T. [1 ]
Tsao, Philip S. [2 ]
机构：
[1] Hannover Med Sch, Dept Nephrol, D-30625 Hannover, Germany
[2] Stanford Univ, Sch Med, Div Cardiovasc Med, Falk CVRC, Stanford, CA 94305 USA
来源：
JOURNAL OF NEPHROLOGY | 2007年 / 20卷 / 05期
关键词：
OXIDE SYNTHASE INHIBITOR; ASYMMETRIC DIMETHYLARGININE CONCENTRATIONS; INSULIN-RESISTANCE; WEIGHT-LOSS; DISEASE; OBESE; DIMETHYLAMINOHYDROLASE; MORTALITY; HUMANS; MARKER;
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：515 / 517
页数：3
相关论文
共 20 条
[1]   A nitric oxide-mediated mechanism regulates lipolysis in human adipose tissue in vivo [J].
Andersson, K ;
Gaudiot, N ;
Ribiere, C ;
Elizalde, M ;
Giudicelli, Y ;
Arner, P .
BRITISH JOURNAL OF PHARMACOLOGY, 1999, 126 (07) :1639-1645
[2]   Metformin treatment lowers asymmetric dimethylarginine concentrations in patients with type 2 diabetes [J].
Asagami, T ;
Abbasi, F ;
Stuelinger, M ;
Lamendola, C ;
McLaughlin, T ;
Cooke, JP ;
Reaven, GM ;
Tsao, PS .
METABOLISM-CLINICAL AND EXPERIMENTAL, 2002, 51 (07) :843-846
[3]   Asymmetrical dimethylarginine - The Uber marker? [J].
Cooke, JP .
CIRCULATION, 2004, 109 (15) :1813-1818
[4]   Relationship between obesity, smoking, and the endogenous nitric oxide synthase inhibitor, asymmetric dimethylarginine [J].
Eid, HMA ;
Arnesen, H ;
Hjerkinn, EM ;
Lyberg, T ;
Seljeflot, I .
METABOLISM-CLINICAL AND EXPERIMENTAL, 2004, 53 (12) :1574-1579
[5]   Historical perspective: visceral obesity and related comorbidity in Joannes Baptista Morgagni's 'De sedibus et Causis Morborum per Anatomen Indagata' [J].
Enzi, G ;
Busetto, L ;
Inelmen, EM ;
Coin, A ;
Sergi, G .
INTERNATIONAL JOURNAL OF OBESITY, 2003, 27 (04) :534-535
[6]   ADMA increases arterial stiffness and decreases cerebral blood flow in humans [J].
Kielstein, Jan T. ;
Donnerstag, Frank ;
Gasper, Sandra ;
Menne, Jan ;
Kielstein, Anousheh ;
Martens-Lobenhoffer, Jens ;
Scalera, Fortunato ;
Cooke, John P. ;
Fliser, Danilo ;
Bode-Boeger, Stefanie M. .
STROKE, 2006, 37 (08) :2024-2029
[7]   Cardiovascular effects of systemic nitric oxide synthase inhibition with asymmetrical dimethylarginine in humans [J].
Kielstein, JT ;
Impraim, B ;
Simmel, S ;
Bode-Böger, SM ;
Tsikas, D ;
Frölich, JC ;
Hoeper, MM ;
Haller, H ;
Fliser, D .
CIRCULATION, 2004, 109 (02) :172-177
[8]   Asymmetric dimethylarginine: A cardiovascular risk factor and a uremic toxin coming of age? [J].
Kielstein, JT ;
Zoccali, C .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2005, 46 (02) :186-202
[9]   Weight loss reduces circulating asymmetrical dimethylarginine concentrations in morbidly obese women [J].
Krzyzanowska, K ;
Mittermayer, F ;
Kopp, HP ;
Wolzt, M ;
Schernthaner, G .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (12) :6277-6281
[10]   Impaired nitric oxide synthase pathway in diabetes mellitus - Role of asymmetric dimethylarginine and dimethylarginine dimethylaminohydrolase [J].
Lin, KY ;
Ito, A ;
Asagami, T ;
Tsao, PS ;
Adimoolam, S ;
Kimoto, M ;
Tsuji, H ;
Reaven, GM ;
Cooke, JP .
CIRCULATION, 2002, 106 (08) :987-992
12